510(k) K190677
K190677 is an FDA 510(k) premarket notification submitted by Endoclot Plus Co., Ltd. for the device "EndoClot". The FDA issued a decision of Substantially Equivalent on Jan 29, 2021. The device falls under product code QAU (Hemostatic Device For Endoscopic Gastrointestinal Use), a Class II device regulated under 21 CFR 878.4456. Endoclot Plus Co., Ltd. has 3 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jan 29, 2021
- Date Received
- Mar 15, 2019
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Hemostatic Device For Endoscopic Gastrointestinal Use
- Device Class
- Class II
- Regulation Number
- 878.4456
- Review Panel
- SU
- Submission Type
- 510(k)
Hemostatic device for intraluminal gastrointestinal use. A hemostatic device for intraluminal gastrointestinal use is a prescription device that is endoscopically applied to the upper and/or lower gastrointestinal tract and is intended to produce hemostasis via absorption of fluid or by other physical means.
Need the full FDA record for Endoclot Plus Co., Ltd.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.